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Background: Nucleotide-binding oligomerizing domain-1 (NOD1) is a cytoplasmic receptor involved in recognizing
bacterial peptidoglycan fragments that localize to the cytosol. NOD1 activation triggers inflammation, antimicrobial
mechanisms and autophagy in both epithelial cells and murine macrophages. NOD1 mediates intracellular
pathogen clearance in the lungs of mice; however, little is known about NOD1’s role in human alveolar
macrophages (AMs) or its involvement in Mycobacterium tuberculosis (Mtb) infection.
Methods: AMs, monocytes (MNs), and monocyte-derived macrophages (MDMs) from healthy subjects were
assayed for NOD1 expression. Cells were stimulated with the NOD1 ligand Tri-DAP and cytokine production
and autophagy were assessed. Cells were infected with Mtb and treated with Tri-DAP post-infection. CFUs
counting determined growth control, and autophagy protein recruitment to pathogen localization sites was
analyzed by immunoelectron microscopy.
Results: NOD1 was expressed in AMs, MDMs and to a lesser extent MNs. Tri-DAP stimulation induced NOD1
up-regulation and a significant production of IL1β, IL6, IL8, and TNFα in AMs and MDMs; however, the level
of NOD1-dependent response in MNs was limited. Autophagy activity determined by expression of proteins
Atg9, LC3, IRGM and p62 degradation was induced in a NOD1-dependent manner in AMs and MDMs but not
in MNs. Infected AMs could be activated by stimulation with Tri-DAP to control the intracellular growth of
Mtb. In addition, recruitment of NOD1 and the autophagy proteins IRGM and LC3 to the Mtb localization site
was observed in infected AMs after treatment with Tri-DAP.
Conclusions: NOD1 is involved in AM and MDM innate responses, which include proinflammatory cytokines
and autophagy, with potential implications in the killing of Mtb in humans.
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Pathogen recognition and induction of innate immune re-
sponses are important for the efficient elimination of in-
fection. The nucleotide-oligomerizing domain 1 (NOD1)
pattern recognition receptor senses the cytosolic presence
of meso-diaminopimelic acid (DAP)-containing peptido-
glycan fragments derived predominantly from the cell
walls of gram-negative bacteria and M. tuberculosis [1,2].
Following microbial sensing, NOD1 directly recruits a
serine–threonine kinase, Receptor-interacting protein
2 (Rip2), which initiates a signal cascade that ultim-
ately allows NF-κB to translocate to the nucleus [3].
Stimulating NOD1 induces the secretion of proinflam-
matory cytokines and chemokines (IL-6, IL-8, CXCL1,
MIP-2, CCL2, and CCL5), the production of anti-
microbial peptides (β-defensins), and autophagy in human
epithelial cells [4-6].
Recent evidence reveals a major role for NOD1 in the
resolution of respiratory infections. NOD1-deficient mice
have an impaired ability to eliminate pulmonary Legion-
ella pneumophila and to recruit neutrophils to the lungs
[7]; clearance of Streptococcus pneumoniae and Haemoph-
ilus influenzae also occurs via a NOD1-dependent manner
in a murine model of co-infection [8]. Rip2−/− mice show
reduced iNOS expression and delayed neutrophil recruit-
ment to the lungs and an inability to clear Chlamydophila
pneumoniae infections, which subsequently lead to an in-
creased rate of mortality [9]. Despite the evidence for
NOD1’s role in resolving pulmonary infections, there are
no data to support its role in M. tuberculosis infections.
Alveolar macrophages (AMs) are responsible for mi-
crobial lung clearance by orchestrating inflammatory re-
sponses that stimulate epithelial lung cells to produce
additional chemokines and antimicrobial peptides, which
amplify innate responses and help recruit other cells,
such as monocytes and neutrophils [10]. AMs are also
the cells responsible for eliminating M. tuberculosis. Al-
though antimicrobial activity may be induced by NOD1,
the involvement of AMs in NOD1-mediated responses
and the full spectrum of cellular mechanisms responsible
for antimicrobial NOD1-dependent activity, in mice and
humans, remain to be elucidated.
In the present study, we investigate the presence of
NOD1 in human AMs and examine its involvement with
inflammatory cytokines and the induction of antimicro-
bial autophagy. For comparison, we include monocytes
and monocyte-derived macrophages, as human mono-
cytic cells have been reported to initiate proinflamma-
tory responses following NOD1 ligand recognition [11].
Because NOD1 and autophagy are involved in intracellu-
lar pathogen clearance, we also analyze the role of
NOD1 activation in the control of M. tuberculosis infec-
tion. Finally, we describe a novel role for NOD1 in pri-
mary human AM innate responses.Methods
Ethics statement
The subjects for this study were healthy nonsmokers with
a median age of 24 (range 20–40) years, 25% female, 75%
male, seronegative for HIV-1, and no history of pulmonary
or cardiac disease or recent infections. These subjects
were studied after giving a signed informed consent, ac-
cording to the Declaration of Helsinki, for bronchoalveo-
lar lavage and venipuncture. The National Institute for
Respiratory Diseases (INER) Institutional Review Board in
Mexico City approved this protocol.
Cells
Human bronchoalveolar cells were obtained by bron-
choscopy, as previously described [12]. Cells were col-
lected in sterile saline solutions and centrifuged at 400 × g
for 15 minutes at 4°C. The pellets from the bronchoalveo-
lar cells were suspended in culture medium, and the via-
bility of the bronchoalveolar cells was assessed by Trypan
blue exclusion (>98% in all cases). Bronchoalveolar cells
were found to be 94.3 ± 2.8% alveolar macrophages ac-
cording to flow cytometric analysis using a gate based on
size and granularity. Therefore, we will refer to these cells
as alveolar macrophages (AMs) in this study.
Monocyte-derived macrophages (MDMs) were obtained
from peripheral blood mononuclear cells (PBMCs) that
were prepared by centrifugation of whole heparinized ven-
ous blood diluted 1/1 with RPMI 1640 (Lonza, Walkers-
ville, MD, USA) over a Lymphocyte separation solution
(Lonza) gradient. PBMCs were plated in polystyrene
dishes and incubated for 1 h at 37°C, in 5% CO2. After dis-
carding non-adherent cells and extensive washings, the
monocytes were recovered using a cell lifter. The viability
of the monocytes was assessed by Trypan blue exclusion
and was greater than 98% in all cases. MN concentrations
were adjusted to 106 cells/ml and were incubated on 24-
well plates at 37°C, in 5% CO2 for 7 days, which allowed
them to differentiate into MDMs that adhered to plastic
[13]. MNs and MDMs were assayed for NOD1 activation.
In all of the experiments, the culture medium consisted
of RPMI 1640 supplemented with 50 μg/mL gentamycin
sulfate, 200 mM L-glutamine, and 10% heat-inactivated
pooled human serum.
Cell stimulation
To assess ligand-induced responses, 106 AMs, MDMs, and
MNs were cultured in a final volume of 1 mL in an ultra-
low attachment polystyrene 24-well plate (Corning Inc.,
NY, USA). The cells were stimulated using 5 μg/mL
of synthetic L-Ala-γ-D-Glu-meso-diaminopimelic acid
(Tri-DAP) (InvivoGen, San Diego, CA, USA) for 24 h.
Next, the supernatants were collected and kept frozen
until the cytokine assessment; the cells were harvested
and prepared for protein or mRNA extraction. Culture
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was used as a positive control, as indicated. In selected
experiments, 10 μM of Rip2/p38 inhibitor SB203580
(Promega, Madison, WI, USA), 20 μM of PI3K inhibitor
LY294002 (Promega) and 20 μM of pan-caspases inhibitor
Z-VAD-fmk (Calbiochem, La Joya, CA, USA) were added
to the cells 30 minutes before Tri-DAP stimulation to
block NOD1 signaling.
Reverse transcription and real-time PCR for gene
expression
Total RNA was extracted and reverse transcribed as pre-
viously reported [13]. The cDNA was subjected to quan-
titative real-time PCR (qRT-PCR, TaqMan) to determine
the NOD1, LC3 and IRGM mRNA expression levels
using the comparative threshold cycle (ΔΔCt) as de-
scribed previously [14]. Real-time PCR reactions were
performed in duplicate wells according to the manufac-
turer’s protocol for Taqman predesigned gene assays;
NOD1 (Hs01036717_m1), LC3 (Hs00171082_m1 and
IRGM (Hs01013699_s1) were purchased from Applied
Biosystems (Carlsbad, CA, USA). The Ct values for each
gene were normalized to the endogenous control gene
18S rRNA (4319413E).
Cytokine detection
Supernatants of 24-h cultures were assayed for the re-
lease of IL1β, IL6, IL8, IL10, IL12p70, IFNα2, and TNFα
cytokines using the Milliplex human cytokine detec-
tion kit (Millipore, Billerica, MA, USA) according to the
manufacturer’s protocol.
Immunoblot
Proteins extracted from cytoplasmic lysates were sepa-
rated by SDS-PAGE and transferred to polyvinylidene
difluoride membranes, as previously described [14].
Briefly, membranes were blocked and incubated with the
following antibodies: anti-human NOD1 (AdB serotec,
Raleigh, NC, USA), IRGM (Abcam, Cambridge, MA),
Atg9, and LC3 (Novus Biologicals, Littleton, CA, USA) or
α-tubulin (Sigma-Aldrich, St. Louis, MO, USA) for 2 h
followed by an incubation with peroxidase-conjugated
anti-rabbit or anti-mouse IgG antibody (Sigma-Aldrich)
for 1 h at room temperature. Specific bands were detected
with the chemiluminescence SuperSignal system (Thermo,
Rockford, IL, USA) and were revealed using autoradio-
graphic films. Densitometry was performed using ImageJ
1.44o (National Institutes of Health, USA).
Transduction of p62 to assess autophagic flux
MDMs were seeded in 8-well chamber slides (Thermo) at
5 × 105 cells/well. The cells were transduced with 15 viral
particles per cell for ectopical expression of p62-RFP
(Premo Autophagy Sensor p62 kit, Molecular Probes,Carlsbad, CA). After 18 h, the cells were stimulated with
5 μg/ml of Tri-DAP and incubated for 5 or 24 h at 37°C
and 5% CO2. Chloroquine 60 μM and medium were used
as controls. We used Lysotracker (Molecular Probes) to
stain lysosomes and Hoescht 33342 (Enzo Life Sciences,
Farmingdale, NY) to stain nuclei following the manufac-
turer’s instructions. Cells were visualized in an AxioScope.
A1 microscope (Carl Zeiss, Oberkochen, Germany) with
the appropriate fluorescence filters. Images were acquired
and analyzed with ZEN Pro software (Carl Zeiss).
Infection with Mycobacterium tuberculosis and post-
infection treatment
M. tuberculosis (Mtb) strain H37Rv (ATCC 25618) was
grown as previously described [12]. AMs (105) were in-
fected with Mtb in RPMI with 30% non-heat-inactivated,
pooled human AB serum at an infection ratio of 1–2
bacteria/20 cells in 96-well polystyrene plates; they were
incubated for 1 h followed by three washes to remove
any non-phagocytized bacteria. The cells were then cul-
tured for another hour in RPMI supplemented with 10%
heat-inactivated pooled human serum with or without
5 μg/ml of Tri-DAP. The infected macrophages were in-
cubated after Tri-DAP treatment for 1 h (Day 0), 24 h
(Day 1) and 96 h (Day 4) to evaluate the effects of macro-
phages on mycobacterial intracellular growth by quantify-
ing the colony-forming units (CFUs). The intracellular
growth index was calculated as the ratio of CFUs at Day 1
or 4 relative to the CFUs at Day 0.
AMs were infected with a multiplicity of infection
(MOI) of 5 using 4 × 106 cells cultured in polypropylene
tubes under the same conditions described above and
analyzed by transmission electron microscopy. Cells
were treated with Tri-DAP with or without prior inhib-
ition of Rip2/p38 and PI3K for 24 h post-infection and
fixed in preparation for electron microscopy detection
and subcellular localization of proteins.
Electron microscopy
The subcellular localization of IRGM and LC3 proteins
was performed using transmission electron microscopy
(TEM), as previously described [15]. Briefly, cells were
fixed in 4% paraformaldehyde in 0.2 M Sörensen buffer;
the samples were dehydrated with increasing concentra-
tions of ethylic alcohol and infiltrated with LR-White
hydrosoluble resin (London Resin Co., Hampshire, United
Kingdom). Sections that were 60- to 80-nm-thick were
placed on nickel grids. The grids were incubated overnight
at 4°C with specific polyclonal rabbit anti-IRGM (Abcam)
and anti-LC3 (Novus Biologicals) antibodies followed by a
2 h incubation at room temperature with goat anti-rabbit
IgG (Sigma-Aldrich) conjugated to 5-nm gold particles
(Sigma-Aldrich) and diluted 1:20 in PBS. The grids were
contrasted with uranyl acetate (Electron Microscopy
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M-10 Zeiss electron microscope (Karl Zeiss, Jena, Germany).
To quantitatively assess autophagy protein recruitment
to the mycobacteria-containing vesicle, we performed
morphometric analyses by counting gold particles that
colocalized with bacteria in 10 randomly selected cells
from each condition (10–18 bacteria/condition) using
ImageJ software.
Statistical analysis
Data of paired samples from related subjects were ana-
lyzed by a non-parametric two-tailed Wilcoxon signed-
rank test. Comparisons among non-related samples were
analyzed using a Mann–Whitney U test. The colocaliza-
tion of gold particles with bacteria between treatments
was analyzed using a two-tailed paired t-test. The means
and standard errors (SEs) were calculated where indicated.
A p-value of p < 0.05 was considered a statistically signifi-
cant difference. The statistical analyses were performed
using SPSS 15.0 for Windows (SPSS, Chicago, IL, USA)
and GraphPad Prism, version 5.0 (GraphPad Software
Inc., San Diego, CA, USA).
Results
NOD1 is up-regulated in AMs and MDMs, but not in
monocytes, after ligand stimulation
Differences in Toll-like receptor patterns have been previ-
ously described between differentiated macrophages andFigure 1 Differential NOD1 expression and response patterns betwee
alveolar macrophages (AMs), monocyte-derived macrophages (MDMs) and
from the cytosolic fractions by western blot analysis; one representative ex
expression after normalized to tubulin is depicted, n = 3 (B). Total RNA was
expression is depicted relative to the 18S RNA content of at least 9 subject
the presence or absence of 5 μg/ml of Tri-DAP for 24 h. Up-regulation of N
Taqman system and ΔΔCT for relative quantification. The fold changes of
are depicted; the lines indicate the median values; *p < 0.05, Mann Whitneymonocytes [13]; therefore, we investigated whether NOD1
was expressed in unstimulated AMs, MDMs, and MNs.
We observed a basal protein expression in all cell popula-
tions studied (Figure 1A) and densitometry revealed that
NOD1 was more abundant in AMs (Figure 1B). We did
not observe significant differences in the relative abun-
dance of NOD1 mRNA in unstimulated cells (Figure 1C).
However, after stimulation with Tri-DAP, AMs signifi-
cantly up-regulated their NOD1 mRNA levels relative to
the unstimulated cells, while MDMs barely modulated
their gene expression and MNs showed down-regulated
NOD1 levels (p < 0.05 vs. AMs, Figure 1D).
NOD1 stimulation with Tri-DAP induces proinflammatory
cytokines in AMs and MDMs
NOD1 pathogen recognition is typically accompanied by
proinflammatory cytokine production [16]. AMs are re-
sponsible for initiating inflammatory responses, which
recruit large numbers of neutrophils into the alveolar
spaces to clear bacteria from entering terminal airways
[17]. In this study, we have determined that Tri-DAP
stimulation of macrophages in 24 h cultured superna-
tants results in pro-inflammatory cytokine production.
We found that AMs release significant amounts of IL1β,
IL6, TNFα, and IL8 (p < 0.05, Figure 2A). Meanwhile,
MDMs released significant quantities of IL1β, TNFα,
and IL8 (p < 0.05), and remarkably, MNs only produce
significant amounts of IL1β in response to Tri-DAPn differentiated macrophages and monocytes. Unstimulated
monocytes (MNs) were lysed. NOD1 protein expression was measured
periment out of three is depicted (A) and the mean ± SE of protein
extracted from cell lysates and reverse transcribed. NOD1 gene
s; the lines represent the median values (C). Cells were incubated in
OD1 gene expression was assessed by quantitative PCR using the
gene expression relative to the unstimulated cells of at least 9 subjects
U test (D).
Figure 2 Macrophages stimulated with Tri-DAP release proinflammatory cytokines. Cells were incubated in the presence or absence of
5 μg/ml of Tri-DAP (n = 10, A) or 100 ng/ml of LPS (n = 8, B). The supernatants were collected after 24 h; cytokine production was measured using
milliplex technology. Box plots indicate median and quartiles, *p < 0.05, **p < 0.01, ns = not significant Wilcoxon Rank test.
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tested, we did not find any anti-inflammatory production
of IL10 after Tri-DAP exposure (data not shown). In
addition, AMs, the maximum responders to Tri-DAP
stimulation, were also assayed for IL12p70, IFNα, and
IL17; we found that AMs do not produce these cytokines
in response to NOD1 ligand binding (data not shown).
To confirm the selectivity of NOD1’s proinflammatoryresponse, we stimulated AMs, the highest responders,
and MNs, the lowest responders, with 100 ng/ml of
LPS and observed that significant amounts of TNFα,
IL6, and IL10 were released from both cell types (p < 0.05,
compared to medium), and the levels of cytokine produc-
tion were similar in both cells (Figure 2B). Cytokine re-
sponses were confirmed by qPCR using cell lysate-derived
cDNAs (data not shown).
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stimulation with NOD1 ligand
NOD1 induces autophagy in epithelial cells [6], and we re-
cently found that NOD2 activation induces autophagy in hu-
man AMs as part of their antibacterial pulmonary defenseFigure 3 After stimulation with the NOD1 ligand, macrophages increa
Alveolar macrophages (AMs), monocyte-derived macrophages (MDMs) and
Tri-DAP for 24 h. Cells were pre-incubated with Rip2/p38 inhibitor SB20358
responses, as indicated. Atg9 and LC3 proteins were measured in the cytos
the unstimulated cells were calculated after being normalized to tubulin, m
expression was assessed after specific ligand recognition by quantitative PC
The fold changes in gene expression relative to the unstimulated cells of at le
IRGM protein was measured in the cytosolic fractions of three subjects by we
indicated after being normalized to tubulin; mean ± SE is depicted, n = 3 (E, F[14]. Thus, we evaluated the ability of NOD1 to induce au-
tophagy in different macrophages by determining the expres-
sion of the autophagy proteins Atg9 and LC3 after Tri-DAP
exposure. We found that the expression of Atg9 increased
after NOD1 stimulation in AMs and MDMs (Figure 3A).sed their expression of autophagy proteins Atg9, LC3 and IRGM.
monocytes (MNs) were incubated in the presence of 5 μg/ml of
0 (SB) for 30 min prior to Tri-DAP stimulation to block NOD1-mediated
olic fractions by western blot analysis (A). The fold increases relative to
ean ± SE is depicted, n = 3 (B, C). The up-regulation of IRGM gene
R using the Taqman system and ΔΔCT method for relative quantification.
ast 6 subjects are depicted; bold lines indicate medians, *p < 0.05 (D).
stern blot, and the fold increases relative to the unstimulated cells are
).
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hibitor SB203580 for 30 min prior to Tri-DAP stimulation
blocked NOD1-mediated responses and blocked the in-
creased expression of Atg9 (Figure 3A,B). NOD1 activa-
tion also induced an increment in LC3-I and II in AMs
and MDMs (Figure 3A,C). In contrast, no increase in
autophagy proteins was observed in MNs. The enzyme
IRGM is a key autophagy component with antimicrobial
functions. Thus, we analyzed IRGM expression levels and
determined that IRGM gene expression was elevated in
AMs after Tri-DAP exposure, slightly increased in MDMs,
and decreased in MNs (Figure 3D). Consistent with the
gene expression data, only the AMs overexpress IRGM
protein after Tri-DAP stimulation (Figure 3E,F).
To confirm that autophagy was productive, we used ec-
topically expressed p62 in MDMs as an indicator of au-
tophagic flux. The p62/SQSTM1 is a receptor for cargo
destined to be degraded by autophagy [18]. Because the
vector does not replicate within mammal cells, p62 is de-
graded when autophagy occurs and an accumulation ofFigure 4 Autophagy induced after stimulation with the NOD1 ligand
during 18 h. Cells were incubated in the presence of 5 μg/ml of Tri-DAP fo
evaluated by fluorescence microscopy (A). Lysotracker and Hoescht were u
was included as autophagic flux blocker. Transduction levels of p62 (5 h) a
p62 puncta (B) and colocalization with lysotracker (C). The mean ± SE of tw
for each condition.p62 positive vesicles indicate lack of autophagic flux. After
24 h of Tri-DAP treatment we observed cells with p62
puncta (Figure 4A). When we compared p62 puncta
values obtained at 5 h to those of 24 h an evident reduc-
tion in p62 was observed confirming the development of
productive autophagy (Figure 4B). In addition, most of the
p62 puncta of Tri-DAP treated cells colocalyzed with lyso-
tracker (Figure 4C). Chloroquine, as expected, induced au-
tophagy but blocked the fusion autophagosomes-lysosome
thus preventing the completion of the autophagic flux.
Tri-DAP stimulation confines M. tuberculosis to
autophagic vesicles and helps control intracellular growth
Our results reveal that NOD1 activation induces an anti-
bacterial state in AMs, which may improve the control of
intracellular pathogenic infections. Therefore, we evaluated
the role of NOD1 stimulation during in vitro infections
with Mtb, one of the most successful intracellular patho-
gens. Previously, we demonstrated that Tri-DAP-treated
AMs develop autophagy (Figures 3 and 4). Therefore, wein MDMs was productive. MDMs were transduced with p62-RFP
r 24 h. Accumulation of p62 in autophagosomes (puncta) was
sed to stain lysosomes and nuclei, respectively. Choloroquine 60 μM
nd autophagy induction (24 h) were evaluated by counting cells with
o independent experiments is depicted. Up to 300 cells were counted
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cruitment of IRGM and LC3 to Mtb-containing vesicles
in AMs infected with Mtb that were treated or non-
treated with Tri-DAP. Our results demonstrate that when
AMs are treated with Tri-DAP post-infection, the Mtb is
enclosed in autophagic vesicles that are positive for
autophagy proteins, such as IRGM and LC3, whereas
a minimum recruitment of these proteins is observed in
the untreated macrophages (Figure 5A-D). To confirmFigure 5 NOD1-dependent induction of autophagy contributes to IRG
infected with M. tuberculosis H37Rv using an infection ratio of 5 bacteria/m
Then, the macrophages were treated with 5 μg/ml of Tri-DAP for 24 h. Cel
hibitor LY294002 (LY) for 30 min prior to Tri-DAP stimulation which blocks
localization of autophagy proteins was observed in untreated (A, C) and Tr
which were detected using a secondary antibody coupled to 5 nm gold p
calizing with bacteria were manually counted in 10 macrophages of each c
cated: ***p < 0.01 and *p < 0.05 vs. Mtb, ++p < 0.01 vs. Tri-DAP, Wilcoxon Rwhether the recruitment of IRGM and LC3, as well as
autophagy, were dependent on NOD1 signaling, we pre-
incubated cells with Rip2/p38 (SB) and PI3K (LY) inhibi-
tors prior to Tri-DAP stimulation (Additional file 1). The
use of both inhibitors significantly diminished the recruit-
ment of autophagy proteins to the Mtb-containing vesicle
(Figure 5E, F). In absence of stimulation the expression of
IRGM was very low, and LC3 was homogeneously distrib-
uted within the cytosol (Additional file 2).M and LC3 recruitment to Mtb-containing vesicles. AMs were
acrophage for 1 h. Non-phagocytized bacteria were washed away.
ls were pre-incubated with Rip2/p38 inhibitor SB203580 (SB) or PI3K in-
NOD1- or autophagy-mediated responses, as indicated. The subcellular
i-DAP treated cells (B, D) using anti-IRGM and anti-LC3 antibodies,
articles (indicated with arrowheads; TEM X 62,000). Gold particles colo-
ondition (E, F) and the differences between the treatments are indi-
ank test. Box plots indicate median and quartiles.
Figure 6 Tri-DAP treatment contributes to intracellular growth
control of mycobacteria in alveolar macrophages. AMs were
infected with M. tuberculosis H37Rv using an infection ratio of 1–2
bacteria/20 macrophages for 1 h. Non-phagocytized bacteria were
washed away. Then, the macrophages were treated with 5 μg/ml of
Tri-DAP for 24 h. The intracellular bacterial burden was measured by
quantifying the colony-forming units, and the intracellular growth
index was calculated after 1 and 4 days post-infection relative to the
phagocytized bacteria at day 0; n = 7, *p < 0.05 (A). TNFα production
was determined by ELISA in 24 h supernatants, n = 7, *p < 0.05, box
plots indicate median and quartiles (B). LC3 gene expression was
measured by quantitative PCR using the Taqman system and ΔΔCT
method for relative quantification. The fold changes in gene
expression relative to the unstimulated cells of at least 8 subjects
are depicted; bold lines indicate medians (C).
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proves the control of Mtb-intracellular growth. The
intracellular growth index revealed that bacterial growth
was lower inside AMs when they were treated with Tri-
DAP post-infection (Figure 6A) compared with the in-
fected AMs that did not receive Tri-DAP stimulation.
Moreover, Tri-DAP stimulation induced the release of
significant amounts of TNFα and the overexpression of
LC3 mRNA in AMs infected with Mtb (Figure 6B,C) that
were not observed in AMs when they were not treated
with Tri-DAP.
Discussion
The nucleotide-oligomerizing domain 1 (NOD1) pattern
recognition receptor is essential in respiratory innate
defense. NOD1 deficiencies cause severe respiratory dis-
eases and impair antibacterial mechanisms in mouse
models [7,9]. Human lung epithelial cells contribute to
the clearance of attenuated K. pneumoniae by producing
beta-defensins in a TLR2- and NOD1-dependent man-
ner, which highlights the importance of NOD1 in re-
spiratory pathogen elimination and in pathogen-evasion
mechanisms in human pneumonia [19]. However, the
role of NOD1 in human AM responses remains un-
known. In the current study, we investigate the role of
NOD1 in the primary human AM innate response, fo-
cusing on the proinflammatory effectors and the induc-
tion of autophagy.
First, we determined the intracellular expression of
NOD1 in unstimulated primary human AMs and com-
pared their NOD1 expression levels with those of MNs
and MDMs. We determined that NOD1 was expressed
in the cytosol of AMs, MNs, and MDMs. The NOD1
mRNA levels in unstimulated AMs are similar to those
in MDMs and MNs, indicating that NOD1 expression is
independent of cell differentiation and that AMs, MNs,
and MDMs could potentially respond to stimulation by
NOD1 ligands. However, NOD1 gene expression was
only up-regulated in AMs after Tri-DAP stimulation;
neither the MDMs nor the MNs increased their NOD1
gene expression, which suggests that regulation or the
functional ability of the receptor is cell type-dependent.
In agreement with ligand-induced NOD1 overexpres-
sion, we observed a broader proinflammatory cytokine
profile triggered by NOD1 in AMs. Alveolar macrophages
produce significant quantities of TNFα, IL6, IL1β, and
IL8; MDMs produce all of these cytokines except IL6;
however, the MN response is restricted to IL1β. The low
cytokine response observed in MNs is consistent with pre-
vious reports, which indicate that human PBMCs or puri-
fied MNs do not release pro-inflammatory cytokines after
low concentrations of Tri-DAP stimulation. Instead, they
synergize with TLR ligands to induce strong cytokine
responses. However, increased Tri-DAP concentrations
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kine responses elicited by NOD1 stimulation depend on
the stage of maturation and the specific requirements of
the tissue. AMs produce increased levels of IL8, which
suggests a role for NOD1-dependent neutrophil recruit-
ment to human lungs. Meanwhile, other reports suggest
that NOD1 responses induce not only neutrophil recruit-
ment but also an increased neutrophil-killing capacity
[22,23]. NOD1 induces the production of proinflamma-
tory cytokines, which is critical for bacterial clearance in
mice with L. pneumophila [24].
One of the antimicrobial mechanisms induced by in-
nate receptors is autophagy, which is inducible by
NOD1 in epithelial cells [6]. Therefore, we investigated
whether macrophages could initiate autophagy in re-
sponse to NOD1 ligand stimulation. We investigated the
expression of the autophagy-related proteins Atg9, LC3,
and IRGM after stimulation with Tri-DAP and found that
AMs increase the expression of Atg9 and LC3. These re-
sults indicate that the autophagy process is involved be-
cause Atg9 is necessary for initiating autophagosome
formation and LC3 is required to finalize autophagosome
maturation [25,26]. Moreover, the degradation of p62 con-
firms the autophagy completion. In addition, NOD1 in-
duces the overexpression of IRGM in AMs, which implies
an antimicrobial component because human and murine
IRGM not only induce autophagy but also collaborate to
eliminate intracellular pathogens, including Mtb [27,28].
Taken together, our results suggest that AMs are highly
responsive to NOD1 stimulation, MDMs elicit moderate
innate responses after Tri-DAP stimulation, and MNs ex-
hibit a limited response. Thus, although basal expression is
similar, regulation of NOD1 expression levels, the quality
and magnitude of NOD1-driven cytokine and autophagy
responses are associated with the macrophage differenti-
ation status and the tissue environment of the cell, which
explains why higher responses are observed in AMs and
MDMs.
Autophagy constitutes an important mechanism of
defense against Mtb [29]. In this study, because autoph-
agy was mainly induced in AMs, we evaluated the anti-
microbial activity associated with autophagy in AMs.
We infected AMs with Mtb as a model intracellular
pathogen and evaluated the effect of NOD1 activation as
an inducer of autophagy after an established infection.
Some Mtb virulence factors inhibit autophagy in host
macrophages to grant survival [30,31]. Therefore, Tri-DAP
was added post-infection to overcome Mtb-associated in-
hibition of autophagy. After treating infected AMs with
Tri-DAP, we observed recruitment of autophagy indicators,
such as IRGM and LC3, to the pathogen-containing vesi-
cles in a Rip2-dependent manner. Rip2-dependent and
-independent responses have been documented for NOD1
and NOD2 [6]. LC3 and IRGM up-regulation have beenused to measure autophagy because they are induced in
human AMs after NOD2 activation [14]. Autophagy pro-
teins did not increase and they were not recruited to
pathogen-containing vesicles in the cells incubated with
Rip2/p38 inhibitor prior to Tri-DAP stimulation. There-
fore, our results indicate that the NOD1 ligand also in-
duces autophagy in a Rip2-dependent manner in AMs.
Autophagosomes become degradation compartments that
influence phagosome maturation and pathogen degrad-
ation [32]. Therefore, the NOD1-dependent formation of
autophagosomes may have improved the control of the
intracellular mycobacterial burden that we observed in
AMs.
Conclusions
The results of our study demonstrate the presence of
NOD1 in AMs for the first time and show that this recep-
tor is functionally active. These studies provide evidence
that NOD1 induces the production of proinflammatory
mediators and triggers autophagy mechanism in human
alveolar macrophages. The antimicrobial profile activated
by NOD1 may be of relevance, especially early after pul-
monary microbe invasion. The induction of autophagy in
AMs after NOD1 activation is a significant mechanism for
eliminating intracellular microbes that enter the alveolar
space, such as M. tuberculosis. NOD1 and NOD2 induce
autophagy and recruitment of neutrophils and macro-
phages and have a role in defense against M. tuberculosis
[33,34]; therefore, ligands of both receptors are potential
candidates for use as immunomodulators in tuberculosis
infection. Further studies are needed to elucidate whether
activating the NOD1 receptor also induces other aspects
of the AM immune response.
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